• 948 Citations
  • 16 h-Index
1988 …2018
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Andrea Nozza is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 21 Similar Profiles
Multiple Myeloma Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Dexamethasone Medicine & Life Sciences
Lymphoma Medicine & Life Sciences
Stem Cell Transplantation Medicine & Life Sciences
Hodgkin Disease Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Ifosfamide Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1988 2018

  • 948 Citations
  • 16 h-Index
  • 43 Article
  • 1 Review article

Long-Term Follow-Up of a Donor versus No-Donor Comparison in Patients with Multiple Myeloma in First Relapse after Failing Autologous Transplantation

Patriarca, F., Bruno, B., Einsele, H., Spina, F., Giaccone, L., Montefusco, V., Isola, M., Nozzoli, C., Nozza, A., Morabito, F., Corradini, P. & Fanin, R., 2018, In : Biology of Blood and Marrow Transplantation. 24, 2, p. 406-409 4 p.

Research output: Contribution to journalArticle

Long-Term Follow-Up of a Donor versus No-Donor Comparison in Patients with Multiple Myeloma in First Relapse after Failing Autologous Transplantation

Patriarca, F., Bruno, B., Einsele, H., Spina, F., Giaccone, L., Montefusco, V., Isola, M., Nozzoli, C., Nozza, A., Morabito, F., Corradini, P. & Fanin, R., Feb 2018, In : Biology of Blood and Marrow Transplantation. 24, 2, p. 406-409 4 p.

Research output: Contribution to journalArticle

Autologous Transplantation
Multiple Myeloma
Tissue Donors
Recurrence
Stem Cell Transplantation

Siltuximab in relapsed/refractory multicentric Castleman disease: Experience of the Italian NPP program

Tonialini, L., Bonfichi, M., Ferrero, S., Malipiero, G., Nozza, A., Argnani, L. & Zinzani, P. L., Jan 1 2018, In : Hematological Oncology.

Research output: Contribution to journalArticle

siltuximab
Multi-centric Castleman's Disease
Italy
Recurrence
Pruritus

Siltuximab in relapsed/refractory multicentric Castleman disease: Experience of the Italian NPP program

Tonialini, L., Bonfichi, M., Ferrero, S., Malipiero, G., Nozza, A., Argnani, L. & Zinzani, P. L., Jan 1 2018, (Accepted/In press) In : Hematological Oncology.

Research output: Contribution to journalArticle

siltuximab
Multi-centric Castleman's Disease
Italy
Recurrence
Pruritus